Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy

NCT00299884 · clinicaltrials.gov ↗

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Dyslipidemia
Vascular Disease

Interventions

DRUG: Lipitor 20 mg
DRUG: Combination Ezetrol 10 mg and Lipidil Supra 160 mg

Sponsor

Queen's University